CXCR3 antagonists
    9.
    发明授权
    CXCR3 antagonists 有权
    CXCR3拮抗剂

    公开(公告)号:US06794379B2

    公开(公告)日:2004-09-21

    申请号:US10164690

    申请日:2002-06-06

    IPC分类号: A61K3133

    摘要: Compounds, compositions and methods that are useful in the treatment of inflammatory and immune conditions and diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of a chemokine receptor. The subject methods are useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes.

    摘要翻译: 本文提供了可用于治疗炎症和免疫疾病和疾病的化合物,组合物和方法。 特别地,本发明提供调节趋化因子受体的表达和/或功能的化合物。 本发明的方法可用于治疗炎性和免疫调节性疾病和疾病,例如多发性硬化,类风湿性关节炎和I型糖尿病。